Literature DB >> 30014193

Quality of care in hospitalized cancer patients before and after implementation of a systematic prevention program for delirium: the DELTA exploratory trial.

Asao Ogawa1,2, Yasuyuki Okumura3, Daisuke Fujisawa4,5, Hiroyuki Takei6, Chiyuki Sasaki7, Kei Hirai8, Yusuke Kanno9, Kensuke Higa10, Yasuhiko Ichida11, Asuko Sekimoto7, Chie Asanuma7.   

Abstract

BACKGROUND: We evaluated whether the DELirium Team Approach (DELTA) program-a systematic management program aimed at screening high-risk groups and preventing delirium-would improve quality of care in patients hospitalized with cancer.
METHODS: A retrospective before-after study was conducted during a pre-intervention period (between October 2012 and March 2013) and a post-intervention period (between October 2013 and March 2014) at a Japanese hospital providing specialized treatments for cancer. A total of 4180 inpatients were evaluated before the implementation of the DELTA program and 3797 inpatients were evaluated after implementation.
RESULTS: After program implementation, the incidence of delirium decreased from 7.1 to 4.3% (odds ratio [OR], 0.52; 95% CI, 0.42-0.64). The incidence of adverse events, including falls or self-extubation, also decreased, from 3.5 to 2.6% (OR, 0.71; 95% CI, 0.54-0.92). There was a significant decrease in the prescription of benzodiazepines (OR, 0.79; 95% CI, 0.71-0.87), increase in the level of independence in activities of daily living at discharge (OR, 1.94; 95% CI, 1.11-3.38), and decrease in the length of stay (risk ratio 0.90; 95% CI, 0.90-0.90).
CONCLUSIONS: The systematic management program for delirium decreased the incidence of delirium and improved several clinical outcomes. These data suggest that this simple cost-effective program is feasible and implementable as routine care in busy wards.

Entities:  

Keywords:  Cancer; Cognitive impairment; Delirium; Education program; Prevention

Mesh:

Year:  2018        PMID: 30014193     DOI: 10.1007/s00520-018-4341-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  6 in total

Review 1.  Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer-Related Pain.

Authors:  Esad Ulker; Egidio Del Fabbro
Journal:  Oncologist       Date:  2019-12-24

Review 2.  The detection of delirium in admitted oncology patients: a scoping review.

Authors:  Megan B Sands; Ian Wee; Meera Agar; Janette L Vardy
Journal:  Eur Geriatr Med       Date:  2022-01-15       Impact factor: 1.710

3.  Pilot Study of Lemborexant for Insomnia in Cancer Patients with Delirium.

Authors:  Tatsuto Terada; Takatoshi Hirayama; Ryoichi Sadahiro; Saho Wada; Rika Nakahara; Hiromichi Matsuoka
Journal:  J Palliat Med       Date:  2022-01-28       Impact factor: 2.947

4.  Nursing support for symptoms in patients with cancer and caregiver burdens: a scoping review protocol.

Authors:  Jun Kako; Masamitsu Kobayashi; Yusuke Kanno; Kohei Kajiwara; Kimiko Nakano; Miharu Morikawa; Yoshinobu Matsuda; Yoichi Shimizu; Megumi Hori; Mariko Niino; Miho Suzuki; Taichi Shimazu
Journal:  BMJ Open       Date:  2022-09-14       Impact factor: 3.006

5.  Demographic and clinical characteristics of patients with delirium: analysis of a nationwide Japanese medical database.

Authors:  Naoya Ueda; Masakazu Igarashi; Kotoba Okuyama; Hideki Sano; Kanae Takahashi; Zaina P Qureshi; Shigeru Tokita; Asao Ogawa; Yasuyuki Okumura; Shoki Okuda
Journal:  BMJ Open       Date:  2022-09-14       Impact factor: 3.006

6.  Impact of a delirium prevention project among older hospitalized patients who underwent orthopedic surgery: a retrospective cohort study.

Authors:  Jung-Yeon Choi; Kwang-Il Kim; Min-Gu Kang; Young-Kyun Lee; Kyung-Hoi Koo; Joo Han Oh; Young Ho Park; Jeewon Suh; Nak-Hyun Kim; Hyun-Jung Yoo; Jahyun Koo; Hyun Mi Moon; Eun Hui Kim; Kayoung Park; Cheol-Ho Kim
Journal:  BMC Geriatr       Date:  2019-10-26       Impact factor: 3.921

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.